This years American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, presented major advances in hematology, with >6,000 abstracts submitted. In this video, Kenneth Anderson, MD, of the Dana-Farber Cancer Institute, Boston, MA, this years ASH President, discusses the highlights of the meeting. Dr Anderson emphasizes the number of approved novel treatments and paradigm-changing agents, including those presented in late-breaking abstracts. He also draws attention to the focus on CAR T-cell therapy at the meeting this year, with this therapy now being investigated for many types of leukemia and lymphoma, as well as multiple myeloma, with impressive responses even in advanced disease.
